These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 99155)

  • 21. Specific afterload reduction with parenteral hydralazine following cardiac surgery.
    Sladen RN; Rosenthal MH
    J Thorac Cardiovasc Surg; 1979 Aug; 78(2):195-202. PubMed ID: 459526
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vasodilator treatment with isosorbide dinitrate and hydralazine in chronic heart failure.
    Massie BM; Kramer B; Shen E; Haughom F
    Br Heart J; 1981 Apr; 45(4):376-84. PubMed ID: 7225252
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [New aspects of the treatment of left ventricular failure: Nitroglycerin (author's transl)].
    Bussmann WD
    Med Klin; 1975 Oct; 70(42):1697-1706. PubMed ID: 810653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the acute hemodynamic and coronary vasodilating effects between nicorandil and glyceryl trinitrate.
    Chibana T; Nagamine F; Sunagawa R; Oshiro K; Nakada Y; Shimabukuro M; Shinzato T; Murakami K; Mimura G; Sakanashi M
    Arzneimittelforschung; 1991 Jun; 41(6):591-4. PubMed ID: 1834065
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of intravenous nitroglycerin on hemodynamics of congestive heart failure.
    Pitt WA; Friedman RG; Gross SA; Glassman J; Keating EC; Mazur JH
    Angiology; 1982 May; 33(5):294-301. PubMed ID: 6805373
    [No Abstract]   [Full Text] [Related]  

  • 26. Intravenous glyceryl trinitrate (nitroglycerin). A review of its pharmacological properties and therapeutic efficacy.
    Sorkin EM; Brogden RN; Romankiewicz JA
    Drugs; 1984 Jan; 27(1):45-80. PubMed ID: 6420139
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The influence of transdermal glyceryl trinitrate on peripheral circulation in healthy subjects and in patients with congestive cardiac failure.
    Duprez D; De Pue N; Jordaens L; Clement D
    Eur J Clin Pharmacol; 1987; 33(1):73-5. PubMed ID: 3121352
    [No Abstract]   [Full Text] [Related]  

  • 28. Acute effect of hydralazine administration on pulmonary artery hemodynamics in dogs with chronic heartworm disease.
    Atkins CE; Keene BW; McGuirk SM; Sato T
    Am J Vet Res; 1994 Feb; 55(2):262-9. PubMed ID: 8172418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pulsus alternans induced by glyceryl trinitrate paste in a patient with alcoholic cardiomyopathy.
    Chandraratna PA; Langevin E; Langevin J
    Br Heart J; 1979 Mar; 41(3):354-5. PubMed ID: 154916
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acquired tolerance to dilator action of hydrallazine during oral administration.
    Robinson BF; Collier JG; Dobbs RJ
    Br J Clin Pharmacol; 1980 Apr; 9(4):407-12. PubMed ID: 6769454
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Haemodynamic effects after application of nitroglycerin sublingually or as ointment in patients with left ventricular heart failure (author's transl)].
    Magometschnigg D; Bonelli J; Gassner A; Lenzhofer R; Kleinberger G; Pall H; Pichler M
    Wien Klin Wochenschr; 1980 Jan; 92(1):24-6. PubMed ID: 6769256
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of haemodynamic effects of oral prazosin, oral hydralazine, and intravenous nitroprusside in same patients with chronic heart failure.
    Mehta J; Iacona M; Pepine CJ; Conti CR
    Br Heart J; 1979 Dec; 42(6):664-70. PubMed ID: 534583
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multicenter studies of 2% nitroglycerin ointment in patients with heart failure.
    Kawai C; Kambara H; Nakano T; Hirota Y; Saito M; Kagoshima T; Nobuyoshi M; Tsuruha Y
    Clin Ther; 1984; 6(5):677-88. PubMed ID: 6434184
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hydralazine does not ameliorate nitric oxide resistance in chronic heart failure.
    Chirkov YY; De Sciscio M; Sverdlov AL; Leslie S; Sage PR; Horowitz JD
    Cardiovasc Drugs Ther; 2010 Apr; 24(2):131-7. PubMed ID: 20490904
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute and chronic arterial and venous effects of captopril in congestive cardiac failure.
    Capewell S; Taverner D; Hannan WJ; Muir AL
    BMJ; 1989 Oct; 299(6705):942-5. PubMed ID: 2508945
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preload and afterload without anguish: a simplified framework.
    Mandell HN; Deglin SM
    Postgrad Med; 1982 May; 71(5):105-12. PubMed ID: 6803231
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of captopril and a combination of hydralazine and isosorbide dinitrate on myocardial sympathetic tone in patients with severe congestive heart failure.
    Daly P; Rouleau JL; Cousineau D; Burgess JH; Chatterjee K
    Br Heart J; 1986 Aug; 56(2):152-7. PubMed ID: 3524637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sustained haemodynamic action of nitroglycerin ointment.
    Meister SG; Engel TR; Guiha N; Furr CM; Feitosa GS; Hart K; Frankl WS
    Br Heart J; 1976 Oct; 38(10):1031-6. PubMed ID: 823949
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Haemodynamic effects of hydralazine at rest and during exercise in patients with chronic heart failure.
    Ginks WR; Redwood DR
    Br Heart J; 1980 Sep; 44(3):259-64. PubMed ID: 7426183
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Haemodynamic adaptation at rest and during exercise to long-term antihypertensive treatment with combination of beta-receptor blocking and vasodilator agent.
    Koch G
    Br Heart J; 1976 Dec; 38(12):1240-6. PubMed ID: 1008968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.